Bioabsorbable Therapeutics

About:

Bioabsorbable Therapeutics, Inc. develops and commercializes medical devices for treating coronary and peripheral vascular diseases. Its

Website: http://www.bioabsorbabletx.com/

Top Investors: Western Technology Investment, Finistere Ventures, Synergy Ventures, MedFocus Fund, Teton Capital Advisers

Description:

Bioabsorbable Therapeutics, Inc. develops and commercializes medical devices for treating coronary and peripheral vascular diseases. Its products include Whisper coronary stent system, a balloon-expandable fully absorbable coronary stent; and Unison Peripheral Stent System, a self-expanding fully absorbable peripheral stent. The company uses anti-inflammatory polymers to develop bioabsorbable coatings and stents. Bioabsorbable Therapeutics, Inc. was founded in 2004 and is based in Menlo Park, California.

Total Funding Amount:

$9.36M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2004-01-01

Founders:

Patrick Rivelli

Number of Employees:

11-50

Last Funding Date:

2009-03-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai